Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF



GREY:TSTIF - Post by User

Post by StocksFTBon Dec 17, 2018 6:11pm
192 Views
Post# 29126517

what is wrong with this picture

what is wrong with this picture
The statement  below is from the is from the Dec 10th updated safety communication about rates of duodenoscope infections.   

"However, it has become clear that following the manufacturer’s reprocessing and maintenance instructions, while critical, is not sufficient to avoid all infections associated with the use of duodenoscopes. That is why the FDA has also been working with developers on new product designs, including disposable components. Technological advances in product design hold promise to reduce the risk of contamination and enhance patient safety"


Why does the FDA not simply state the VP4 as a solution to this problem?  Why do they continue to talk about new product design holding promise when the VP4 is apparently approved to solve this issue?  This does not make sense.  Who has a reasonable explanation?



https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm628096.htm  
<< Previous
Bullboard Posts
Next >>